98
- Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to
defi ning functional ability in ankylosing spondylitis: the development of the bath ankylosing
spondylitis functional index. J Rheumatol. 1994;21(12):2281–5. - Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defi ning
spinal mobility in ankylosing spondylitis (AS). The bath as metrology index. J Rheumatol.
1994;21(9):1694–8. - Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an
ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann
Rheum Dis. 2009;68(1):18–24. - Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a func-
tional index and an articular index in ankylosing spondylitis. J Rheumatol.
1988;15(2):302–7. - Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham vascu-
litis activity score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87(11):671–8. - Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development
and initial validation of the vasculitis damage index for the standardized clinical assessment
of damage in the systemic vasculitides. Arthritis Rheum. 1997;40(2):371–80. - Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al. A disease-
specifi c activity index for Wegener's granulomatosis: modifi cation of the Birmingham vascu-
litis activity score. International network for the study of the systemic vasculitides (INSSYS).
Arthritis Rheum. 2001;44(4):912–20. - Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, et al. Damage caused by
Wegener's granulomatosis and its treatment: prospective data from the Wegener's
Granulomatosis Etanercept Trial (WGET). Arthritis Rheum. 2005;52(7):2168–78. - Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of
WOMAC: a health status instrument for measuring clinically important patient relevant out-
comes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.
J Rheumatol. 1988;15(12):1833–40. - Burckhardt CS, Clark SR, Bennett RM. The fi bromyalgia impact questionnaire: development
and validation. J Rheumatol. 1991;18(5):728–33. - van Riel PL. Provisional guidelines for measuring disease activity in clinical trials on rheu-
matoid arthritis. Br J Rheumatol. 1992;31(12):793–4. - Tugwell P, Boers M. Omeract conference on outcome measures in rheumatoid arthritis clini-
cal trials: introduction. J Rheumatol. 1993;20(3):528–30. - Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, et al. Minimal disease activ-
ity for rheumatoid arthritis: a preliminary defi nition. J Rheumatol. 2005;32(10):2016–24. - Sharp JT. Scoring radiographic abnormalities in rheumatoid arthritis. J Rheumatol.
1989;16(5):568–9. - Sharp JT. Assessment of radiographic abnormalities in rheumatoid arthritis: what have we
accomplished and where should we go from here? J Rheumatol. 1995;22(9):1787–91. - Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radio-
logic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory
abnormalities. Arthritis Rheum. 1971;14(6):706–20. - van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method.
J Rheumatol. 2000;27(1):261–3. - Landewe R, van der Heijde D. Radiographic progression in rheumatoid arthritis. Clin Exp
Rheumatol. 2005;23(5 Suppl 39):S63–8. - Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in
long-term studies. J Rheumatol. 1995;22(10):1974–5. - Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related condi-
tions by standard reference fi lms. Acta Radiol. 1977;18(4):481–91. - Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A. A new method of scoring radiographic
change in rheumatoid arthritis. J Rheumatol. 1998;25(11):2094–107.
T. Pincus et al.